Greatbatch Announces the Acquisition of NeuroNexus

CLARENCE, N.Y.--(BUSINESS WIRE)--Greatbatch, Inc., (NYSE:GB) today announced the acquisition of NeuroNexus Technologies (“NeuroNexus”) for approximately $12 million in cash, including the assumption of debt and future considerations. NeuroNexus, headquartered in Ann Arbor, Michigan, is an active implantable medical device design firm specializing in developing and commercializing high-value neural interface technology, components and systems for neuroscience and clinical markets. The company has

Feed Date: 
February 17, 2012